FIELD: medicine, pediatry. SUBSTANCE: method involves an artificial ventilation and instillation of surface-active substance. Egg yolk is diluted preliminary with physiological solution at volume ratio 1:10 and used as a surface-active substance. EFFECT: enhanced effectiveness of method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING SEVERE RESPIRATORY FAILURE IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2020 |
|
RU2751287C1 |
| METHOD FOR PREDICTION OF BRONCHOPULMONARY DYSPLASIA IN NEWBORNS WITH VERY LOW OR EXTREMELY LOW BIRTH BODY WEIGHT | 2012 |
|
RU2504395C1 |
| DEVICE FOR DRUG DELIVERY INTO LUNG BY MEANS OF CATHETER | 2016 |
|
RU2714183C2 |
| THERAPEUTIC COMBINATION FOR THE TREATMENT OF DEVELOPING BPD CONTAINING PULMONARY SURFACTANT AND STEROID | 2017 |
|
RU2757902C2 |
| METHOD OF PREVENTING BRONCHOPULMONARY DYSPLASIA IN NEWBORN BABIES WITH VERY LOW AND EXTREMELY LOW BODY WEIGHT AT BIRTH | 2009 |
|
RU2416388C1 |
| THERAPEUTIC COMBINATION CONTAINING LUNG SURFACTANT AND STEROID | 2010 |
|
RU2533450C2 |
| METHOD FOR THE TREATMENT OF RESPIRATORY FAILURE AFTER ACUTE RESPIRATORY DISTRESS SYNDROME, REGARDLESS OF ETIOLOGY | 2022 |
|
RU2782103C1 |
| METHOD FOR TREATMENT OF ACUTE PULMONARY INSUFFICIENCY AND DEVICE FOR ITS IMPLEMENTATION SAVELIEVA B.S. | 2020 |
|
RU2745759C1 |
| RECONSTITUTED PULMONARY SURFACTANTS | 2013 |
|
RU2656185C2 |
| METHOD FOR TREATING THE SYNDROME OF PULMONARY LESIONS AFTER EXTENSIVE OPERATIVE INTERFERENCES | 2002 |
|
RU2195958C1 |
